Cargando…

Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro

Interferon-α (IFN-α) has been used for more than 20 years as the first-line therapy for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, because it has a number of antiviral effects. In this study, we describe a novel mode of its antiviral action. We demonstrate that the supernatant fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yuchen, Cheng, Xiaoming, Blossey, Christoph K., Wisskirchen, Karin, Esser, Knud, Protzer, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358466/ https://www.ncbi.nlm.nih.gov/pubmed/28367455 http://dx.doi.org/10.1155/2017/4828936

Ejemplares similares

Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications
por: Wettengel, Jochen M., et al.
Publicado: (2021)

New pharmacological strategies to fight enveloped viruses
por: Wisskirchen, Karin, et al.
Publicado: (2014)

Control of Hepatitis B Virus by Cytokines
por: Xia, Yuchen, et al.
Publicado: (2017)

Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity
por: Altstetter, Sebastian Maximilian, et al.
Publicado: (2021)

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
por: Sautto, Giuseppe A, et al.
Publicado: (2016)

Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors
por: Schreiber, Sophia, et al.
Publicado: (2021)

ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry
por: Shu, Qian, et al.
Publicado: (2015)

Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins
por: Debelec-Butuner, Bilge, et al.
Publicado: (2022)

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use
por: Wisskirchen, Karin, et al.
Publicado: (2017)

Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns
por: Ernandes, Michael J., et al.
Publicado: (2021)

IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection
por: Li, Yong, et al.
Publicado: (2017)

Innate immune recognition and modulation in hepatitis D virus infection
por: Jung, Stephanie, et al.
Publicado: (2020)

Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20
por: Stadler, Daniela, et al.
Publicado: (2021)

Hepatitis E Virus Entry
por: Yin, Xin, et al.
Publicado: (2019)

Regulated Entry of Hepatitis C Virus into Hepatocytes
por: Miao, Zhijiang, et al.
Publicado: (2017)

HIRA in Hepatitis B Virus Minichromosome Regulation: Another Piece of the Puzzle
por: Cheng, Xiaoming, et al.
Publicado: (2022)

Type I interferon rapidly restricts infectious hepatitis C virus particle genesis
por: Meredith, Luke W, et al.
Publicado: (2014)

Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
por: Velkov, Stoyan, et al.
Publicado: (2020)

Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells
por: Tu, Thomas, et al.
Publicado: (2022)

HDVdb: A Comprehensive Hepatitis D Virus Database
por: Usman, Zainab, et al.
Publicado: (2020)

Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
por: Esser, Knud, et al.
Publicado: (2023)

Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro
por: Smith, S. E., et al.
Publicado: (2013)

The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data
por: Velkov, Stoyan, et al.
Publicado: (2018)

Hepatitis B Virus Entry into Cells
por: Herrscher, Charline, et al.
Publicado: (2020)

Hepatitis C virus entry into the hepatocyte
por: Belouzard, Sandrine, et al.
Publicado: (2011)

Concentration of Na(+)-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virus
por: Oswald, Andreas, et al.
Publicado: (2021)

Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection
por: Shevtsov, Maxim, et al.
Publicado: (2017)

SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA
por: Hofmann, Samuel, et al.
Publicado: (2023)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro
por: Helbig, K. J., et al.
Publicado: (2019)

Viral hepatitis and liver cancer
por: Ringehan, Marc, et al.
Publicado: (2017)

Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity
por: Rueschenbaum, Sabrina, et al.
Publicado: (2021)

Grouper interferon-induced transmembrane protein 3 (IFITM3) inhibits the infectivity of iridovirus and nodavirus by restricting viral entry
por: Zhang, Ya, et al.
Publicado: (2020)

Correction to ‘Viral hepatitis and liver cancer’
por: Ringelhan, Marc, et al.
Publicado: (2018)

Recent Advances in Hepatitis C Virus Cell Entry
por: Bartosch, Birke, et al.
Publicado: (2010)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

The pros and cons of entry restrictions: are entry restrictions really effective in preventing the spread of SARS-CoV-2?
por: Park, Donghwi, et al.
Publicado: (2022)

Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry
por: Kuo, Yu-Ting, et al.
Publicado: (2020)

Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus
por: Saito, Takeshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1shgjtfkea5mb87uv0jj78urds